News
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
The House Judiciary Committee has subpoenaed a former Pfizer executive who is considered central to its investigation into an ...
In a 3-0 decision, the 2nd U.S. Circuit Court of Appeals found disputed issues over the sincerity of Jeanette Diaz's ...
13h
MedPage Today on MSNCDC Follows Advice of Ousted Vaccine Panel, Expands Access to RSV ShotThe new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...
TUESDAY, July 1, 2025 (HealthDay News) — On Monday, the U.S. Supreme Court said it will not hear a case brought by a group ...
The Cambridge biotech believes packaging the two immunizations together will lead to higher uptake of COVID vaccines.
WASHINGTON (AP) — The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results